GeneDx (NASDAQ:WGSWW – Get Free Report) is expected to be posting its resultson Monday, August 3rd. Analysts expect GeneDx to announce earnings of ($0.1875) per share and revenue of $111.0090 million for the quarter.
GeneDx Stock Performance
NASDAQ WGSWW opened at $0.00 on Monday. GeneDx has a 1 year low of $0.00 and a 1 year high of $0.13.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Featured Stories
- Five stocks we like better than GeneDx
- These 3 AI Winners Don’t Sell the Tech—They Use It
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
